Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Placebo Hepatitis Virus Infection" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Placebo Hepatitis Virus Infection for you to read. Along with our medical data and news we also list Placebo Hepatitis Virus Infection Clinical Trials, which are updated daily. BioPortfolio also has a large database of Placebo Hepatitis Virus Infection Companies for you to search.
Hepatitis C virus (HCV) infection causes substantial morbidity and mortality, but patients with human immunodeficiency virus (HIV) co-infection are 3 times more likely to develop cirrhosis or liver decompensation than those infected with hepatitis C ...
Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radically modify the way that HBV vertical in...
Studies of individuals who were highly exposed but seronegative (HESN) for HIV infection led to the discovery that homozygosity for the Δ32 deletion mutation in the CCR5 gene prevents viral entry into target cells, and is associated with resistance ...
Hepatitis C virus infection is a common cause of liver disease and of liver cancer in the United States. Through a new study that explores one aspect of how the virus hijacks host cell machinery to replicate itself, UNC Lineberger Comprehensive Cance...
(Medical Xpress)—The hepatitis B virus (HBV), which affects the liver, behaves differently in different people depending on genetics and the age the person is when infected. Ninety-five percent of adults who contract hepatitis B clear the virus aft...
In a letter to the Medical Journal of Australia, a Monash University-led team is asking for hepatitis C virus patients to gain improved access to drugs to prevent liver related deaths. Hepatitis C virus (HCV) infection is a major public health burden in Australia, with estimates of 230,000 people chronically infected.
This month marks the 20th anniversary of Hepatitis Awareness Month and the 4th National Hepatitis Testing Day (May 19) in the United States. Although care and treatment can be life-saving, many of the 3 million persons estimated to be living with hepatitis C virus (HCV) infection are unaware of their infection and are not receiving preventive
The vast majority of people infected with Hepatitis C Virus (HCV) will have chronic infection. Over decades, this can lead to liver disease and liver cancer. In fact, HCV infection is the leading cause of liver transplants in the U.S. Several new drugs have recently come into the market that will likely change the HCV treatment paradigm. However, the effectiveness of these new drugs c...
(European Association for the Study of the Liver) Results presented today at The International Liver Congress 2015, show that alcohol use disorders (AUD) have a serious, negative prognostic outcome with higher mortality risks in the general popula...
This Viewpoint describes clinical progress in eradicating hepatitis C virus infection, but emphasizes the importance of making treatment more cost-effective and accessible to all patients.
Hepatitis C virus (HCV) infection imposes a substantial economic, clinical, and societal burden worldwide. In this Review, Morales and Fabrizi compare the treatment options that are available to patients with HCV infection, before and after renal tra...
Viekirax (ombitasvir / paritaprevir / ritonavir) and Exviera (dasabuvir) is indicated for the treatment of genotype 1 chronic hepatitis C virus (HCV) infection and compensated cirrhosis.
Hepatitis B virus (HBV) infection might increase the risk of developing gastric cancer, according to the results of a new study.
The availability of new protease inhibitors is revolutionising the treatment of hepatitis C virus infection.
Inhibiting virus cell entry by targeting tight junctions cures HCV infection in mice.
Several organizations have recommended scaling up screening for hepatitis C infection. But experts warn that no study has tested whether this will lead to net clinical benefit or harm. Hepatitis C is a virus that can infect and damage the liver.
In the battle between a cell and a virus, either side may resort to subterfuge. Molecular messages, which control the cellular machinery both sides need, are vulnerable to interception or forgery. New research at Rockefeller University has revealed the unique twist on just such a strategy deployed by the liver-infecting hepatitis C virus –
An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice, according to a National Institutes of Health study. The results suggest that the drug, chlorcyclizine HCl (CCZ), potentially could be used to treat the virus in people. Results were published April 8 in Science Translational Medicine.
A Singapore led study has shown that Hepatitis B Virus Infection (HBV) exposure increases the immune system maturation of infants, which may give a better survival advantage to counteract bacterial infection during early life. These findings radicall...
Hepatitis B virus (HBV) infection is associated with gastric cancer, particularly in patients without a family history of gastric cancer, researchers from China report. Reuters Health Information
Once inside a liver cell, the hepatitis C virus must bind to miRNA-122 in order to establish a persistent infection. Researchers have now found an unanticipated consequence of this interaction: By using miRNA-122 for its own ends, the virus appears t...
New research from the University of Southampton has identified how changes in the cell membrane play a pivotal role in how the hepatitis C virus replicates. By understanding this process, the researchers hope to investigate how to prevent the changes and potentially develop therapeutic drugs to combat the hepatitis C virus (HCV), which infects an
Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -- hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly
(Rockefeller University) Once inside a liver cell, the hepatitis C virus must bind to miRNA-122 in order to establish a persistent infection. Researchers at Rockefeller University found an unanticipated consequence of this interaction: By using miRNA...